Veranstaltungen

Empfohlene Veranstaltungen

AKTIV

Updates on ESC heart failure guidelines

BEVORSTEHENDE

Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin

AKTIV

Practicalities of SGLT2 inhibition – pros vs cons

BEVORSTEHENDE

Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF

BEVORSTEHENDE

Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF

AKTIV

Practicalities of SGLT2 inhibition – pros vs cons

BEVORSTEHENDE

Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin

AKTIV

COVID-19 and its implications in heart failure